Cargando…

Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?

There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Partl, Richard, Lukasiak, Katarzyna, Stranz, Bettina, Hassler, Eva, Magyar, Marton, Stranzl-Lawatsch, Heidi, Langsenlehner, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226544/
https://www.ncbi.nlm.nih.gov/pubmed/34070592
http://dx.doi.org/10.3390/diagnostics11060946
_version_ 1783712312041930752
author Partl, Richard
Lukasiak, Katarzyna
Stranz, Bettina
Hassler, Eva
Magyar, Marton
Stranzl-Lawatsch, Heidi
Langsenlehner, Tanja
author_facet Partl, Richard
Lukasiak, Katarzyna
Stranz, Bettina
Hassler, Eva
Magyar, Marton
Stranzl-Lawatsch, Heidi
Langsenlehner, Tanja
author_sort Partl, Richard
collection PubMed
description There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present cohort study was to investigate the association between inflammation-based parameters and the sphincter-preserving surgery rate in patients with low-lying locally advanced rectal cancer (LARC). A total of 848 patients with LARC undergoing radiotherapy from 2004 to 2019 were retrospectively reviewed in order to identify patients with rectal cancer localized ≤6 cm from the anal verge, treated with neo-adjuvant radiochemotherapy (nRCT) and subsequent surgery. Univariable and multivariable analyses were used to investigate the role of pre-treatment inflammatory parameters, including the C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the prediction of sphincter preservation. A total of 363 patients met the inclusion criteria; among them, 210 patients (57.9%) underwent sphincter-preserving surgery, and in 153 patients (42.1%), an abdominoperineal rectum resection was performed. Univariable analysis showed a significant association of the pre-treatment CRP value (OR = 2.548, 95% CI: 1.584–4.097, p < 0.001) with sphincter preservation, whereas the pre-treatment NLR (OR = 1.098, 95% CI: 0.976–1.235, p = 0.120) and PLR (OR = 1.002, 95% CI: 1.000–1.005, p = 0.062) were not significantly associated with the type of surgery. In multivariable analysis, the pre-treatment CRP value (OR = 2.544; 95% CI: 1.314–4.926; p = 0.006) was identified as an independent predictive factor for sphincter-preserving surgery. The findings of the present study suggest that the pre-treatment CRP value represents an independent parameter predicting the probability of sphincter-preserving surgery in patients with low-lying LARC.
format Online
Article
Text
id pubmed-8226544
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82265442021-06-26 Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? Partl, Richard Lukasiak, Katarzyna Stranz, Bettina Hassler, Eva Magyar, Marton Stranzl-Lawatsch, Heidi Langsenlehner, Tanja Diagnostics (Basel) Article There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present cohort study was to investigate the association between inflammation-based parameters and the sphincter-preserving surgery rate in patients with low-lying locally advanced rectal cancer (LARC). A total of 848 patients with LARC undergoing radiotherapy from 2004 to 2019 were retrospectively reviewed in order to identify patients with rectal cancer localized ≤6 cm from the anal verge, treated with neo-adjuvant radiochemotherapy (nRCT) and subsequent surgery. Univariable and multivariable analyses were used to investigate the role of pre-treatment inflammatory parameters, including the C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the prediction of sphincter preservation. A total of 363 patients met the inclusion criteria; among them, 210 patients (57.9%) underwent sphincter-preserving surgery, and in 153 patients (42.1%), an abdominoperineal rectum resection was performed. Univariable analysis showed a significant association of the pre-treatment CRP value (OR = 2.548, 95% CI: 1.584–4.097, p < 0.001) with sphincter preservation, whereas the pre-treatment NLR (OR = 1.098, 95% CI: 0.976–1.235, p = 0.120) and PLR (OR = 1.002, 95% CI: 1.000–1.005, p = 0.062) were not significantly associated with the type of surgery. In multivariable analysis, the pre-treatment CRP value (OR = 2.544; 95% CI: 1.314–4.926; p = 0.006) was identified as an independent predictive factor for sphincter-preserving surgery. The findings of the present study suggest that the pre-treatment CRP value represents an independent parameter predicting the probability of sphincter-preserving surgery in patients with low-lying LARC. MDPI 2021-05-25 /pmc/articles/PMC8226544/ /pubmed/34070592 http://dx.doi.org/10.3390/diagnostics11060946 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Partl, Richard
Lukasiak, Katarzyna
Stranz, Bettina
Hassler, Eva
Magyar, Marton
Stranzl-Lawatsch, Heidi
Langsenlehner, Tanja
Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
title Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
title_full Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
title_fullStr Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
title_full_unstemmed Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
title_short Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
title_sort can pre-treatment inflammatory parameters predict the probability of sphincter-preserving surgery in patients with locally advanced low-lying rectal cancer?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226544/
https://www.ncbi.nlm.nih.gov/pubmed/34070592
http://dx.doi.org/10.3390/diagnostics11060946
work_keys_str_mv AT partlrichard canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer
AT lukasiakkatarzyna canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer
AT stranzbettina canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer
AT hasslereva canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer
AT magyarmarton canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer
AT stranzllawatschheidi canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer
AT langsenlehnertanja canpretreatmentinflammatoryparameterspredicttheprobabilityofsphincterpreservingsurgeryinpatientswithlocallyadvancedlowlyingrectalcancer